Search Results

1 - 10 of 618 items :

  • "insulin resistance" x
Clear All
Insulin Resistance (IR) in Patients with Type 2 Diabetes Mellitus. Identifying Predictors of Insulin Resistance and Establishing a Correlation Between Insulin Resistance and Cardiovascular Risk

References 1. Jianping Ye, Mechanisms of insulin resistance in obesity, Front Med. 2013 Mar; 7(1): 14–24. 2. John R. Petrie, Shinichiro Ueda, et.al, Endothelial Nitric Oxide Production and Insulin Sensitivity A Physiological Link With Implications for Pathogenesis of Cardiovascular Disease, Circulation. 1996;93:1331-1333 3. Jonathan D. Schofield, Yifen Liu et.al, Diabetes Dyslipidemia, Diabetes Ther. 2016 Jun; 7(2): 203–219. 4. Mulnier HE, Seaman HE, Raleigh VS, Soedamah-Muthu SS, Colhoun HM, Lawrenson RA, de Vries CS, Risk of myocardial

Open access
Surrogate Measures of Insulin Resistance in Middle-aged Non-diabetic Subjects

References 1. Ausk KJ, Boyko EJ, Ioannou GN. Insulin resistance predicts mortality in nondiabetic individuals in the U.S. Diabetes Care. 2010;33:1179e85 2. Facchini FS, Hua N, Abbasi F, Reaven GM. Insulin resistance as a predictor of age-related diseases. J Clin Endocrinol Metab. 2001;86:3574-8. 3. McLaughlin TL, Reaven GM. Beyond type 2 diabetes: the need for a clinically useful way to identify insulin resistance. Am J Med. 2003;114:501e2 4. Raynaud E, Perez-Martin A, Brun JF, Benhaddad AA

Open access
A Male with Extreme Subcutaneous Insulin Resistance: A Case Report

R eferences 1. Ballani P, Tran MT, Navar MD, Davidson MB. Clinical experience with U-500 regular insulin in obese, markedly insulin resistant Type-2 diabetic patients. Diabetes Care. 29: 2504-2505, 2006. 2. Mantzoros CS, Flier JS. Insulin resistance: the clinical spectrum. Adv Endocrinol Metab 6: 193–232, 1995. 3. Oo YH, Karam JG, Resta CA. Extreme insulin resistance in a patient with diabetes ketoacidosis and acute myocardial infarction. Case Rep Endocrinol 2013:520904, 2013. 4. Ovalle F. Clinical approach to the patient with

Open access
Effect of Omega-3 Fatty Acids Treatment on Insulin Resistance

References 1. Deedwania P. Hypertension, dyslipidemia, and insulin resistance in patients with diabetes mellitus or the cardiometabolic syndrome: benefits of vasodilating β- blockers. J Clin Hypertens (Greenwich) 13: 52-59, 2011. 2. Henry N. Ginsberg. Insulin resistance and cardiovascular disease. J Clin Invest 106: 453-458, 2000. 3. Steinberger J, Daniels SR, American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young) et al

Open access
Are Vaspin and Omentin-1 Related to Insulin Resistance, Blood Pressure and Inflammation in NAFLD Patients?

, Goverud I, et al. Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2. Journal of Hepatology 2006; 44(6): 1167–74. 10. Yang R-Z, Lee M-J, Hu H, Pray J, Wu H-B, Hansen BC, et al. Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. American Journal of Physiology-Endocrinology and Metabolism 2006; 290(6): E1253–E61. 11. Heiker JT. Vaspin (serpinA12) in obesity, insulin resistance, and inflammation. Journal of Peptide Science 2014; 20

Open access
Relationship between the indexes of insulin resistance and metabolic status in dairy cows during early lactation

REFERENCES 1. De Koster JD, Opsomer G: Insulin resistance in dairy cows. Vet Clin North Am Food Anim Pract 2013, 29(2):299-322. 2. Sundrum A: Metabolic Disorders in the Transition Period Indicate that the Dairy Cows’ Ability to Adapt is Overstressed. Animals 2015, 5: 978-1020. 3. Hayirli A: The role of exogenous insulin in the complex of hepatic lipidosis and ketosis associated with insulin resistance phenomenon in postpartum dairy cattle. Vet. Res. Commun. 2006, 30:749–774. 4. Singh B, Saxena A: Surrogate markers of insulin resistance: A

Open access
Insulin Resistance Markers in Type 1 Diabetes Mellitus

References 1. Ionescu - Tîrgovişte C, Guja C, Brădescu O. Insulinorezistența obișnuită și cea severă. In: Tratat de diabet Paulescu. Ionescu - Tirgoviste C (ed). Publisher Romanian Academy Publishing House, Bucharest, pp 677-684, 2004. 2. Olefsky JM, Kruszynska YT. Insulin resistance. In Ellenberg and Rifkin’s Diabetes Mellitus 6th edition. Porte DJ, Sherwin RS, Baron A (ed). Eds. McGraw-Hill, New York, pp 367-400, 2003. 3. Rosenbloom AL. Obesity, insulin resistance, β- cell autoimmunity and the changing

Open access
The index of insulin resistance (FIRI) is not associated with plasma homocysteine levels in young, non-obese healthy men and women

:190-200. Derosa G., A. D'Angelo, E. Fogari, S. Salvadeo, A. Gravina, I. Ferrari (2007) Effects of nateglinide and glibenclamide on prothrombotic factors in naïve type 2 diabetic patients treated with metformin: A 1-year, double-blind, randomized clinical trial. Internal Med. 47:1837-1846. Duncan M. H., M. M. Singh, P. H. Wise, G. Carter, J. A. Alaghband-Zadeh (1995) A simple measure of insulin resistance. Lancet 346:120-121. Emoto M., H. Kanda, T. Shoji, T. Kawagishi, M. Komatsu, K. Mori (2001). Impact of insulin

Open access
Insulin Resistance, Glycemia and Cortisol Levels in Surgical Patients who Had Preoperative Caloric Load with Amino Acids

References 1. Desborough JP. The stress response to surgery. Br J Anaesth. 2000; 85: 109-17. 2. Blebuyck JJ. The Metabolic Response to stress. An overview and update. Аnesthesiology. 1990; 73: 308-27. 3. Burton D, Nicholson G, Hall G. Endocrine and metabolic response to surgery. Critical Care & Pain. 2004; 4: 144-147. 4. Black PR, Brooks DC, Beasey PQ at al. Мechanisms of insulin resistance following injury. Ann Surg. 1984; 196: 420-435. 5. Umpierrez GE, Isaacs SD, Bazargan N at

Open access
in PRILOZI
The relation of anthropometric measurements and insulin resistance in patients with polycystic kidney disease

Introduction Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disease which is associated with progressive deterioration of renal functions. [ 1 ] End-stage renal disease (ESRD) is observed in 25% of patients aged <50 years and 50% of patients aged <60 years. [ 2 ] Insulin resistance (IR) accompanies diabetes mellitus (DM), hypertension, dyslipidemia, glucose intolerance, and hyperuricemia in metabolic and cardiovascular disorders (CVDs). [ 3 ] There are controversial reports in terms of IR in patients with ADPKD

Open access